⌘K

Home/Filings/4/0001213900-25-086581

4//SEC Filing

Maness Timothy 4

Accession 0001213900-25-086581

CIK 0001938571other

View on SEC.gov Company Profile

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 4:59 PM ET

Size

5.7 KB

Accession

0001213900-25-086581

Insider Transaction Report

Form 4

Period: 2025-09-08

ADAPTIN BIO, INC.NONE

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2025-09-08+192,231→ 192,231 total
Exercise: $4.40Exp: 2035-09-07→ Common Stock (192,231 underlying)

Footnotes (1)

[F1]50% of the stock option vested on September 8, 2025. The remaining 50% of the stock option vests in equal monthly installments on the last day of each calendar month over 48 months, beginning on September 8, 2025.

Documents

1 file

4
marketforms-70721.xmlPrimary
PRIMARY DOCUMENT

Issuer

ADAPTIN BIO, INC.

CIK 0001938571

Entity typeother

Related Parties

1

filerCIK 0001774294

Filing Metadata

Form type: 4
Filed: Sep 9, 8:00 PM ET
Accepted: Sep 10, 4:59 PM ET
Size: 5.7 KB

View on SEC.gov